Incyte Corp (NAS:INCY)
$ 57.05 0 (0%) Market Cap: 12.83 Bil Enterprise Value: 9.01 Bil PE Ratio: 17.29 PB Ratio: 2.38 GF Score: 86/100

Incyte Corp at Evercore ISI HealthCONx Conference Transcript

Nov 30, 2023 / 05:30PM GMT
Release Date Price: $54.34 (+1.78%)
Gavin Clark;Gartner
Evercore ISI Institutional Equities, Research Division - Analyst

All right. Welcome, everyone. This is Gavin Clark-Gartner with the Evercore ISI Biotech research team, and I'm really happy to be here with the Incyte team. We have Herve Hoppenot, who is the CEO; and we have Christiana Stamoulis, the Chief Financial Officer. Thanks for joining.

Christiana Stamoulis
Incyte Corporation - Executive VP & CFO

Thank you.

Herve Hoppenot
Incyte Corporation - CEO & Chairman

Thank you for inviting us in Miami.

Gavin Clark;Gartner
Evercore ISI Institutional Equities, Research Division - Analyst

Absolutely. All right. Maybe I'll just kind of turn it over for any opening remarks, if there's anything you want to frame or hit on first?

Herve Hoppenot
Incyte Corporation - CEO & Chairman

I mean, I can try to quickly describe a little bit where we are in the evolution of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot